WallStSmart

Cardinal Health Inc (CAH)vsCencora Inc. (COR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cencora Inc. generates 30% more annual revenue ($325.78B vs $250.74B). CAH leads profitability with a 0.6% profit margin vs 0.5%. COR appears more attractively valued with a PEG of 0.72. COR earns a higher WallStSmart Score of 62/100 (C+).

CAH

Hold

47

out of 100

Grade: D+

Growth: 4.7Profit: 4.5Value: 7.3Quality: 5.8
Piotroski: 4/9Altman Z: 4.30

COR

Buy

62

out of 100

Grade: C+

Growth: 6.7Profit: 6.0Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CAHUndervalued (+73.8%)

Margin of Safety

+73.8%

Fair Value

$855.66

Current Price

$196.97

$658.68 discount

UndervaluedFair: $855.66Overvalued
CORUndervalued (+70.9%)

Margin of Safety

+70.9%

Fair Value

$1255.08

Current Price

$305.90

$949.18 discount

UndervaluedFair: $1255.08Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CAH2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.3010/10

Safe zone — low bankruptcy risk

Free Cash FlowQuality
$1.68B8/10

Generating 1.7B in free cash flow

COR3 strengths · Avg: 9.0/10
Return on EquityProfitability
133.5%10/10

Every $100 of equity generates 134 in profit

Market CapQuality
$59.07B9/10

Large-cap with strong market position

PEG RatioValuation
0.728/10

Growing faster than its price suggests

Areas to Watch

CAH4 concerns · Avg: 3.3/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.6%3/10

0.6% margin — thin

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

COR4 concerns · Avg: 3.0/10
P/E RatioValuation
36.5x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
0.5%3/10

0.5% margin — thin

Operating MarginProfitability
1.2%3/10

Operating margin of 1.2%

Price/BookValuation
31.2x2/10

Trading at 31.2x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : CAH

The strongest argument for CAH centers on Altman Z-Score, Free Cash Flow. Revenue growth of 11.0% demonstrates continued momentum. PEG of 1.26 suggests the stock is reasonably priced for its growth.

Bull Case : COR

The strongest argument for COR centers on Return on Equity, Market Cap, PEG Ratio. PEG of 0.72 suggests the stock is reasonably priced for its growth.

Bear Case : CAH

The primary concerns for CAH are P/E Ratio, Return on Equity, Profit Margin. Thin 0.6% margins leave little buffer for downturns.

Bear Case : COR

The primary concerns for COR are P/E Ratio, Profit Margin, Operating Margin. Thin 0.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

CAH carries more volatility with a beta of 0.65 — expect wider price swings.

CAH is growing revenue faster at 11.0% — sustainability is the question.

CAH generates stronger free cash flow (1.7B), providing more financial flexibility.

Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

COR scores higher overall (62/100 vs 47/100). CAH offers better value entry with a 73.8% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cardinal Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cardinal Health, Inc. is an American multinational health care services company.

Visit Website →

Cencora Inc.

HEALTHCARE · MEDICAL DISTRIBUTION · USA

CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.

Want to dig deeper into these stocks?